Newsfeeds - Spark Newswire

2 minute read

Uncategorized

Pfizer Hits Deadlock With India Over Vaccine Indemnity Issue: Reuters

Today, 9:02 PM

Pfizer Inc (NYSE: PFE) and the Indian government are at loggerheads over a demand by the company for legal protection from any claims linked to the use of its COVID-19 vaccine, said

AZN

1 minute read

Uncategorized

From Axios Event: National Institutes For Health’s Dr. Fauci Says ‘We Will Almost Certainly Require A COVID-19 Booster Shot Within A Year Or So After Getting Primary Shot

By Benzinga Newsdesk

Today, 9:02 PM

-Bloomberg

AZN

2 minute read

Uncategorized

Emergent BioSolutions Stock Falls As Executives Face Questions As Part Of Botched Vaccine Probe

By Vandana Singh

Today, 9:02 PM

The House Select Subcommittee on the Coronavirus announced last month that they were opening an investigation into Emergent BioSolutions Inc (NYSE: EBS),…

EBS

1 minute read

Uncategorized

‘G20 snubs COVID patent waiver, waters down pledge on WHO’s funding’ -Reuters Report

By Benzinga Newsdesk

Today, 9:02 PM

https://www.reuters.com/business/healthcare-pharmaceuticals/exclusive-g20-snubs-covid-patent-waiver-waters-down-pledge-whos-funding-draft-2021-05-18/?taid=60a3b800ee4f3e0001b3aad8&utm_campaign=trueAnthem:+Trending+Co

AZN

1 minute read

Uncategorized

AC Immune Provides Update On Alzheimer’s Disease Vaccine Candidate

By Vandana Singh

Today, 9:02 PM

AC Immune SA (NASDAQ: ACIU) and its partner Janssen Pharmaceuticals Inc have expanded the ongoing Phase 1b/2a trial evaluating anti-phosphorylated-Tau (pTau) vaccine candidate ACI-35.030…

ACIU

3 minute read

Uncategorized

J&J’s Janssen Announced Late-Breaking Data at ACC.21 Show XARELTO Plus Aspirin Significantly Reduced Total Ischemic Events in Peripheral Artery Disease (PAD) Patients After Lower-Extremity Revascularization

By Charles Gross

Today, 9:02 PM

The Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) today presented new data from the Phase 3 VOYAGER PAD study which showed XARELTO® (rivaroxaban) (2.5 mg twice daily) in combination with aspirin (100 mg once daily) consistently reduced severe vascular events in patients with peripheral artery disease (PAD

JNJ

2 minute read

Uncategorized

Here Is What You Can Expect At Major US Stores Following CDC’s New Mask Guidance

By Bibhu Pattnaik

Today, 9:02 PM

The Centers for Disease Control (CDC) has relaxed mask-wearing rules for those fully vaccinated against COVID-19.

AAPL

2 minute read

Uncategorized

What’s Going On With Novavax Stock?

By Shivdeep Dhaliwal

Today, 9:02 PM

Novavax, Inc (NASDAQ: NVAX) shares fell over 12% in the after-hours trading on Monday after closing almost 8.8% lower in regular trading.

BNTX

1 minute read

Uncategorized

FDA To Hold AdCom Meeting For Expanding Use COVID-19 Vaccine In Children

By Vandana Singh

Today, 9:02 PM

The FDA’s Center for Biologics Evaluation and Research (CBER) will convene a virtual meeting of the Vaccines and Related Biological Products Advisory Committee on June 10

AZN

2 minute read

Uncategorized

EMA Safety Committee Reviews Heart Inflammation, Rare Nerve Disorder Reports After Pfizer, AstraZeneca COVID-19 Shots

By Vandana Singh

Today, 9:02 PM

European Medical Agency (EMA) is reviewing reports of a rare nerve-degenerating disorder in people who received AstraZeneca P

AZN